BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 14499719)

  • 1. [Mixed müllerian tumours of the endometrium. About four cases developed on tamoxifen treatment].
    Le Bouëdec G; Penault-Llorca F; de Latour M; Tortochaux J; Dauplat J
    Gynecol Obstet Fertil; 2003 Sep; 31(9):733-8. PubMed ID: 14499719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Mixed mullerian tumours of the endometrium. Four cases developed while on tamoxifen treatment].
    Walker F; Genestie C
    Gynecol Obstet Fertil; 2004 Dec; 32(12):1091-2. PubMed ID: 15589790
    [No Abstract]   [Full Text] [Related]  

  • 3. [Malignant mixed müllerian tumor of the uterus following tamoxifen for breast cancer: case report].
    Saim M; Cote JF; Morel O; Malartic C; Akerman G; Gray F; Barranger E
    Gynecol Obstet Fertil; 2008 Feb; 36(2):166-168. PubMed ID: 18249575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Tamoxifen and endometrial pathology].
    Negoiţă M; Terinte C; Mihailovici MS
    Rev Med Chir Soc Med Nat Iasi; 2010; 114(4):1114-7. PubMed ID: 21500468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The endometrium in breast cancer patients on tamoxifen.
    Dallenbach-Hellweg G; Schmidt D; Hellberg P; Bourne T; Kreuzwieser E; Dören M; Rydh W; Rudenstam G; Granberg S
    Arch Gynecol Obstet; 2000 Apr; 263(4):170-7. PubMed ID: 10834325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Uterine pathology in women with breast cancer treated with tamoxifen].
    Carcangiu ML
    Pathologica; 1997 Jun; 89(3):223-33. PubMed ID: 9380417
    [No Abstract]   [Full Text] [Related]  

  • 7. Sonography and MRI of tamoxifen-associated müllerian adenosarcoma of the uterus.
    Chourmouzi D; Boulogianni G; Zarampoukas T; Drevelengas A
    AJR Am J Roentgenol; 2003 Dec; 181(6):1673-5. PubMed ID: 14627594
    [No Abstract]   [Full Text] [Related]  

  • 8. Malignant mixed Mullerian tumour of uterus secondary to tamoxifen therapy for hormone responsive breast cancer.
    Gupta M; Kiruthiga KG
    BMJ Case Rep; 2015 Jun; 2015():. PubMed ID: 26123463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Müllerian adenosarcoma of the uterus with sarcomatous overgrowth following tamoxifen treatment for breast cancer.
    Carvalho FM; Carvalho JP; Motta EV; Souen J
    Rev Hosp Clin Fac Med Sao Paulo; 2000; 55(1):17-20. PubMed ID: 10881074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Malignant mixed Müllerian tumor of the uterus associated with tamoxifen therapy for breast cancer.
    Magnani KK; Dubey S; Rai S
    Indian J Pathol Microbiol; 2010; 53(4):886-7. PubMed ID: 21045469
    [No Abstract]   [Full Text] [Related]  

  • 11. Carcinosarcoma, endometrial intraepithelial carcinoma and endometriosis after tamoxifen therapy in breast cancer.
    Friedrich M; Villena-Heinsen C; Mink D; Bonkhoff H; Schmidt W
    Eur J Obstet Gynecol Reprod Biol; 1999 Jan; 82(1):85-7. PubMed ID: 10192492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mullerian adenosarcoma of the uterine corpus associated with tamoxifen therapy: a report of six cases and a review of tamoxifen-associated endometrial lesions.
    Clement PB; Oliva E; Young RH
    Int J Gynecol Pathol; 1996 Jul; 15(3):222-9. PubMed ID: 8811383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tamoxifen treatment for breast cancer and risk of endometrial cancer: a case-control study.
    Swerdlow AJ; Jones ME;
    J Natl Cancer Inst; 2005 Mar; 97(5):375-84. PubMed ID: 15741574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased risk of malignant mullerian tumor of the uterus among women with breast cancer treated by tamoxifen.
    Bouchardy C; Verkooijen HM; Fioretta G; Sappino AP; Vlastos G
    J Clin Oncol; 2002 Nov; 20(21):4403. PubMed ID: 12409344
    [No Abstract]   [Full Text] [Related]  

  • 15. Uterine malignant mixed müllerian tumor in a patient on long-term tamoxifen therapy for breast cancer.
    Clarke MR
    Gynecol Oncol; 1993 Dec; 51(3):411-5. PubMed ID: 8112655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Uterine sarcoma in patients receiving tamoxifen therapy. Apropos of 2 cases].
    Le Bouëdec G; Auvray H; Curé H; de Latour M; Penault-Llorca F; Dauplat J
    Rev Med Interne; 2001 Sep; 22(9):881-5. PubMed ID: 11599191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The potential oncogenic effect of tamoxifen on the endometrium.
    Berlière M; Galant C; Donnez J
    Hum Reprod; 1999 May; 14(5):1381-3. PubMed ID: 10325299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uterine malignant mixed Müllerian tumor after adjuvant tamoxifen treatment for breast cancer.
    Grigoriadis C; Androutsopoulos G; Zygouris D; Arnogiannaki N; Terzakis E
    Eur J Gynaecol Oncol; 2013; 34(1):94-8. PubMed ID: 23590011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of malignant mixed mullerian tumors after tamoxifen therapy for breast cancer.
    Curtis RE; Freedman DM; Sherman ME; Fraumeni JF
    J Natl Cancer Inst; 2004 Jan; 96(1):70-4. PubMed ID: 14709741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tamoxifen and malignant epithelial-nonepithelial tumours of the endometrium: report of six cases and review of the literature.
    Treilleux T; Mignotte H; Clement-Chassagne C; Guastalla P; Bailly C
    Eur J Surg Oncol; 1999 Oct; 25(5):477-82. PubMed ID: 10527595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.